Key result
The deployed machine learning model for predicting pediatric chronic kidney disease showed a significant performance drop to an AUROC of 0.63 compared to 0.76 on retrospective data (p=0.033).
Why the study?
The study was conducted to evaluate whether three monitoring metrics could detect performance reductions in a deployed pediatric chronic kidney disease machine learning risk model.
Observational (n=6,149)
No
Standardized mean differences, membership models, and response distribution analysis can provide early indications of performance deterioration in deployed clinical machine learning models.
Performance monitoring metrics for deployed CKD models need prospective validation; leaves open routine clinical use in pediatrics.
Objective The purpose of this study is to evaluate the ability of three metrics to monitor for a reduction in performance of a chronic kidney disease (CKD) model deployed at a pediatric hospital. Methods The CKD risk model estimates a patient's risk of developing CKD 3 to 12 months following an inpatient admission. The model was developed on a retrospective dataset of 4,879 admissions from 2014 to 2018, then run silently on 1,270 admissions from April to October, 2019. Three metrics were used to monitor its performance during the silent phase: (1) standardized mean differences (SMDs); (2) performance of a “membership model”; and (3) response distribution analysis. Observed patient outcomes for the 1,270 admissions were used to calculate prospective model performance and the ability of the three metrics to detect performance changes. Results The deployed model had an area under the receiver-operator curve (AUROC) of 0.63 in the prospective evaluation, which was a significant decrease from an AUROC of 0.76 on retrospective data (p = 0.033). Among the three metrics, SMDs were significantly different for 66/75 (88%) of the model's input variables (p <0.05) between retrospective and deployment data. The membership model was able to discriminate between the two settings (AUROC = 0.71, p <0.0001) and the response distributions were significantly different (p <0.0001) for the two settings. Conclusion This study suggests that the three metrics examined could provide early indication of performance deterioration in deployed models' performance.
No takes yet. Share an insight, caveat, or question.
Morse et al. (2022) conducted an observational in Pediatric Chronic Kidney Disease (n=6,149). Deployed CKD machine learning model vs. Retrospective training data was evaluated on Area under the receiver-operator curve (AUROC) for predicting CKD (p=0.033). The deployed machine learning model for predicting pediatric chronic kidney disease showed a significant performance drop to an AUROC of 0.63 compared to 0.76 on retrospective data (p=0.033).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: